ly 181984 has been researched along with nad in 3 studies
| Studies (ly 181984) | Trials (ly 181984) | Recent Studies (post-2010) (ly 181984) | Studies (nad) | Trials (nad) | Recent Studies (post-2010) (nad) |
|---|---|---|---|---|---|
| 21 | 0 | 0 | 30,121 | 88 | 5,663 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morré, DJ; Morré, DM; Wu, LY | 2 |
| Morré, DJ | 1 |
3 other study(ies) available for ly 181984 and nad
| Article | Year |
|---|---|
The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Division; Cell Membrane; Enzyme Inhibitors; Ethylmaleimide; HeLa Cells; Humans; Kinetics; Liver; Multienzyme Complexes; NAD; NADH, NADPH Oxidoreductases; Octoxynol; Protein Binding; Rats; Sulfonylurea Compounds | 1995 |
NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) at an external site.
Topics: Antineoplastic Agents; Binding Sites; Cell Membrane; HeLa Cells; Humans; Multienzyme Complexes; NAD; NADH, NADPH Oxidoreductases; Sulfonylurea Compounds | 1995 |
Inhibition of NADH oxidase activity and growth of HeLa cells by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) and response to epidermal growth factor.
Topics: Cell Count; Cell Division; Cell Membrane; Drug Synergism; Epidermal Growth Factor; HeLa Cells; Humans; Multienzyme Complexes; NAD; NADH, NADPH Oxidoreductases; Spectrophotometry, Ultraviolet; Sulfonylurea Compounds | 1997 |